FILTER

Refine your search with the following facets to narrow down your results.

5 Current news of Avantogen

Avantogen’s CEO joins Hawaii Biotech Board of Directors

23-Oct-2008 - Avantogen Ltd announced the appointment of Dr William Ardrey, CEO of Avantogen, to the Board of Directors of Hawaii Biotech Inc effective 21 October 2008. Avantogen is focused on commercial licensing and revenue outcomes throughout the group. Avantogen believes that Dr. Ardrey’s appointment to ...

clinical trials Scientific Advisory Boards West Nile Virus

Avantogen’s Hawaii Biotech Inc. receives clinical trial support from Walter Reed Army Institute of Research

03-Sep-2008 - Avantogen Ltd announced additional support for the Dengue vaccine program developed by Hawaii Biotech Inc, in which Avantogen holds a significant investment stake. The Dengue clinical trial will be conducted as part of a broader trial at the clinical trials centre of the US Walter Reed Army ...

clinical trials dengue fever infectious diseases +1

Avantogen's Hawaii Biotechnology Enters Clinic with West Nile Virus Vaccine

25-Jun-2008 - The Directors of Avantogen Ltd announced the clinical trials progress at Hawaii Biotech Inc, where Avantogen has a major shareholding. Dr William Ardrey, CEO of Avantogen, commented "We are pleased to see Hawaii Biotech advance to becoming a clinical stage company, and this also goes a long way ...

biotechnology clinical trials dengue fever +5

Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen's Hawaii Biotech, Inc.

04-Jun-2008 - Avantogen Ltd welcomes Professor Ian Frazer to the Scientific Advisory Board of Hawaii Biotech Inc. (HBI), where Avantogen owns a significant portion of the total equity. Prof Frazer is an immunologist and the 2006 Australian of the Year. HBI is a privately held vaccine development company ...

Scientific Advisory Boards vaccines validation +1

Avantogen Limited appoints Mr. Pat Elliott as Chairman of the Board of Directors

28-May-2008 - The Directors of Avantogen Ltd appointed Mr Pat Elliott as Chairman of the Board. The appointment becomes effective 1 June 2008. Mr Elliott brings a wealth of knowledge and experience in investment banking, leadership and governance skills, corporate finance and strategic transactions. Pat is ...

clinical trials gold Investment +3